Belite Bio Inc (BLTE)
58.39
1.06 (1.85%)
At close: Jan 28, 2025, 2:50 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -31.63M | -12.65M | -9.67M | -5.75M |
| Depreciation & Amortization | 399.00K | 198.00K | 30.00K | 17.00K |
| Stock-Based Compensation | 3.82M | 1.48M | 1.53M | 1.36M |
| Other Working Capital | -2.35M | -459.00K | 640.00K | -73.00K |
| Other Non-Cash Items | 4.69M | 1.91M | -8.00K | 1.39M |
| Deferred Income Tax | -4.69M | -1.91M | n/a | -1.39M |
| Change in Working Capital | -2.43M | -491.00K | 640.00K | -69.00K |
| Operating Cash Flow | -29.84M | -11.46M | -7.47M | -4.44M |
| Capital Expenditures | -63.00K | -394.00K | -74.00K | -20.00K |
| Acquisitions | n/a | n/a | 18.00K | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -394.00K | 18.00K | n/a |
| Investing Cash Flow | -63.00K | -394.00K | -56.00K | -20.00K |
| Debt Repayment | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 75.96M | -1.03M | -583.00K | 57.85M |
| Financial Cash Flow | 75.96M | 36.96M | -583.00K | 28.06M |
| Net Cash Flow | 46.07M | 24.75M | -8.27M | 23.60M |
| Free Cash Flow | -29.90M | -11.85M | -7.55M | -4.46M |